OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Role of Radiomics-based Multiomics Panel in the Microenvironment and Prognosis of Hepatocellular Carcinoma
Ziqian Wu, Siyu Ouyang, Jidong Gao, et al.
Academic Radiology (2025)
Closed Access

The Emerging Role of Histotripsy in Liver Cancer Treatment: A Scoping Review
Heineken Queen, Sarah F. Ferris, Clifford S. Cho, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 915-915
Open Access

Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access

Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access

Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access

Integrating Omics: A New Paradigm in the Management of Hepatocellular Carcinoma
Aymen Bahsoun, Hero K. Hussain
Academic Radiology (2025)
Closed Access

Remodeling the Tumor Immune Microenvironment through Hydrogel Encapsulated G-Rh2 In Situ Vaccine and Systemic Immunotherapy
Chunhua Li, Dan Lei, Yudong Huang, et al.
Materials Today Bio (2024) Vol. 29, pp. 101281-101281
Open Access | Times Cited: 4

Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells
Haoying Yang, Bolei Dai, Liangjie Chen, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1407-1407
Open Access | Times Cited: 2

Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2

Application of nanotechnology in the treatment of hepatocellular carcinoma
Liu Cai, Yanyuan Du, Hongtai Xiong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Subverting Attachment to Prevent Attacking: Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion
Marta Mastrogiovanni, Emmanuel Donnadieu, Rajiv Pathak, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 860-860
Open Access

Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access

[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells
Pan Zhao, Zihui Zhou, Liang Yu, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2131-2136
Closed Access

Page 1

Scroll to top